Comparing Hemoadsorption Devices for Pediatric Sepsis Treatment
Author Information
Author(s): Ryazanova Diana, Tobylbayeva Zaure, Mironova Olga, Kakenov Erken, Sazonov Vitaliy, Hume Janet
Primary Institution: Nazarbayev University, Astana, Kazakhstan
Hypothesis
The study aims to compare the efficacy of HA330 and CytoSorb for extracorporeal blood purification in septic children with oncology.
Conclusion
Both hemoadsorption devices effectively treat septic children with oncological conditions, showing no significant difference in their efficacy.
Supporting Evidence
- Both devices showed similar reduction rates in inflammatory markers.
- Clinical improvement was observed 12–16 hours after the procedure.
- Four deaths were noted, attributed to the progression of underlying oncologic disease.
Takeaway
Doctors tested two machines that clean the blood of sick kids with cancer and found that both worked equally well.
Methodology
This retrospective observational study reviewed 20 cases of pediatric patients with sepsis treated with either HA330 or CytoSorb devices.
Potential Biases
Non-randomized allocation of patients may introduce selection bias.
Limitations
The study had a small sample size and lacked randomization, which may introduce bias.
Participant Demographics
Participants were pediatric patients aged 17 years or younger with various oncological diagnoses.
Statistical Information
P-Value
p>0.05
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website